Prior to 2023, the “X-waiver” requirement prohibited pharmacists from prescribing buprenorphine as treatment for opioid use disorder (OUD). Now that the X-waiver has been eliminated, pharmacists now have more flexibility to engage in team-based OUD treatment via collaborative practice. This podcast will explore potential practice models relating to pharmacist-provided OUD treatment, review current laws and limitations on pharmacists engaging in controlled substance prescribing, and discuss advocacy initiatives to enhance pharmacists’ role as treatment providers.
SPEAKERS
Kyle Robb, PharmD, BCPS currently serves as state policy & advocacy associate at the ASHP. Kyle supports ASHP members and State Affiliates as they seek to advance the practice of pharmacy through engagement with state government.
Kyle is an alumnus of the Virginia Commonwealth University/American College of Clinical Pharmacy/American Society of Health-System Pharmacists Congressional Health Care Policy Fellow Program and served as a Health Policy Fellow on the staff of the U.S. Senate Committee on Health, Education, Labor & Pensions. Prior to working in policy, Kyle was a pharmacist at the University of Virginia Health System.
Anna Dopp, PharmD serves as the senior director of Clinical Guidelines and Quality Improvement at ASHP. Prior to this role, Dr. Dopp served as the Vice President of Public Affairs for the Pharmacy Society of Wisconsin while practicing as a clinical pharmacist at the University of Wisconsin Hospital and Clinics. She also served as a Pharmacy Benefit Consultant with WEA Trust in Madison, WI and a Clinical Assistant Professor at the University of Wisconsin-Madison School of Pharmacy. Dr. Dopp received her Doctor of Pharmacy from the University Of Minnesota College Of Pharmacy and served as a Congressional Health Policy Fellow with the United States Senate.
Tom Kraus is vice president for Government Relations at ASHP. He is a graduate of University of Michigan (BS Biology), Georgetown University Law Center (Doctor Of Law), and The Johns Hopkins University (MHS, Health Policy).
Tom previously served as the Chief of Staff and Associate Commissioner for Legislation at the U.S. Food and Drug Administration. He was also a senior policy advisor to Sen. Ted Kennedy and Sen. Tom Harkin on the Senate Health, Education, Labor and Pensions Committee, where he served as Deputy Staff Director for Health.